The rapid mass testing strategy costing just £1 a day per child can get children back to school and economies up and running, according to experts.
That is the small price of the rapid mass testing across schools in the UK, which is also hard on the heels of one of the world’s swiftest and most successful vaccination programmes.
A double whammy of rapid testing and vaccine deployment applied internationally could lead to a reduction of the human and economic hardship caused by much-criticised lockdown strategies, as well as the continued failure of ‘Track and Trace,’ which has swallowed up £32 billion in the UK.
The UK Government’s investment in vaccines started early, but its equally far-sighted adoption of inexpensive lateral flow test (LFT) kits is less well known.
The economical LFT utilizes nanoparticles to detect virus fragments in a test sample, identifying whether a subject is SARS-CoV-2 asymptomatic within 30 minutes. An individual can immediately isolate after a positive test, preventing transmission of COVID-19 at a rapid pace.
Some early scepticism about the devices has since been overwhelmed by new data and a robust rebuttal from Dr Susan Hopkins, COVID-19 Strategic Response Director to Public Health England, who said:
“Up to one in three people who have coronavirus never show any symptoms (asymptomatic) but that does not mean they are not infectious. Using LFTs enables us to rapidly identify people in the population who are asymptomatic, with results produced in 30 minutes.
“Lateral flow devices are effective at finding people with high viral loads who are most infectious and most likely to transmit the virus to others.”
And she added that the latest data suggested LFTs “are at least 99.9% specific which means that the risk of false positives is extremely low – less than one in a thousand.”
UK Government-sponsored LFT use in workplaces is already widespread, with nearly 50,000 UK businesses already registered for free kits, so that employees can be tested at least twice a week with fast results, enabling them to return to work and their children to get back into the classroom.
Each pupil must take two tests (£3.50 each) a week to show whether they need to be taken out of class to avoid infecting others and the same approach will be used for parents in the workplace.
“That’s remarkable value-for-money. £1 a day for an ‘insurance policy’ to enable schools to open, mums and dads to properly return to work, and the country to accelerate out of lockdown with the re-opening of hospitality and major venues no longer a distant prospect,” said Paul Sheedy, Co-founder of the not-for-profit World Nano Foundation (WNF) that promotes healthcare innovation and believes mass testing kits using nanotechnology are central to future pandemic protection.
Image Credit: Nano
Post by Amanda Scott, NA CEO. Follow her on twitter @tantriclens
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen
News
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]
Researchers Solve the Mystery Behind a Billion-Dollar Dental Implant Disease
Researchers have uncovered why a common and costly dental implant infection often resists antibiotics. Dental implants have helped tens of millions of people regain a full set of stable, functional teeth, something traditional dentures [...]
Nanoparticles inspired by lung fluid improve therapies targeting respiratory system
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated [...]
Scientists Finally Uncover How a “Forever Chemical” Causes Birth Defects
PFDA, a PFAS “forever chemical,” can cause craniofacial birth defects by disrupting retinoic acid regulation during fetal development, revealing the first clear molecular mechanism behind the link. Researchers have long linked perfluoroalkyl and polyfluoroalkyl substances (PFAS), [...]
Scientists Have Discovered These Deadly Parasites Are Secretly Swapping DNA
Leishmania parasites appear to evolve through widespread genetic exchange, reshaping assumptions about how they adapt and spread. A parasite long thought to spread mostly by cloning itself may be far more genetically dynamic than [...]
Stanford’s Revolutionary New Microscope Reveals Living Cells in Stunning Detail
Stanford researchers have developed a microscope that can show how nanostructures interact inside living cells at the highest resolution achieved so far. The view into living cells just got better. Stanford researchers have merged [...]















